HENDERSON, Nev., Oct. 23, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has unveiled what it believes to be an entirely new cancer ...

Malignant brain cancer is aggressive, and biopsies are invasive and painful, but now, some doctors have developed a new method of confirming a diagnosis: a liquid biopsy. Brain cancer’s survival rate ...

A team of researchers has discovered a noninvasive, low-cost test to detect oral cancer, monitor precancerous lesions and determine when a biopsy is warranted. Oral cancers and precancerous mouth ...

CAMBRIDGE, England--(BUSINESS WIRE)--Mursla Bio will present its novel tissue-specific Extracellular Vesicle (EV) isolation technology, NEXPLOR, at the International Society for Extracellular Vesicles ...

Different methods of DNA collection and needle sizes led to varied next-generation sequencing success rates among patients with lung cancer in a recent study. In patients with non–small-cell lung ...

A blood-based liquid biopsy combining cell-free and exosome-bound microRNAs detected early-onset colorectal cancer (CRC) with strong overall diagnostic performance, high sensitivity for early stages, ...

Please provide your email address to receive an email when new articles are posted on . AI-analyzed fragmentomes and protein biomarkers better distinguished women with ovarian cancer in screening.

A study assessing an experimental cell-free DNA myelination liquid biopsy test was found to be 91% accurate at identifying early-stage epithelial ovarian cancer. A recent analysis investigating the ...

WEST LAFAYETTE, Ind. – A team led by researchers at Purdue University and Purdue spinoff company Tymora Analytical Operations has developed a technique that may reveal signs of Parkinson’s disease in ...

Glioblastoma is a brain cancer that can be aggressive and, unfortunately, tricky to diagnose without a biopsy. But a new noninvasive method, tested in mice and pigs, could one day diagnose the disease ...